This summary was created by AI, based on 4 opinions in the last 12 months.
Boston Scientific Corp (BSX-N) is a top pick in the health care business with a successful venture capital fund and a leader in the field. Although the stock is at a new high in terms of price, the consensus is that it will continue to see consistent gains going forward. While there is a 25% downside risk and no yield, the stock is considered fairly nice with a good bounce. Overall, the stock is expected to hold fairly well and is at a premium for a good reason.
Above FMV of $40 by 22%. Growth is fairly nice. He thinks it will hold fairly well. A bouncy kind of stock.
It is at a new high in terms of price but not new highs in terms of Price/Book. There is no yield and a 25% downside risk.
It is a leader in the field so the price is at a premium for a good reason. Has had a good bounce. You could also look at MedTech and Thermo-Fisher.
Boston Scientific Corp is a American stock, trading under the symbol BSX-N on the New York Stock Exchange (BSX). It is usually referred to as NYSE:BSX or BSX-N
In the last year, 4 stock analysts published opinions about BSX-N. 2 analysts recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Boston Scientific Corp.
Boston Scientific Corp was recommended as a Top Pick by on . Read the latest stock experts ratings for Boston Scientific Corp.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
4 stock analysts on Stockchase covered Boston Scientific Corp In the last year. It is a trending stock that is worth watching.
On 2024-03-28, Boston Scientific Corp (BSX-N) stock closed at a price of $68.49.
Still owns shares. Venture capital fund in health care business. One of most successful funds in biotech. Expecting consistent gains going forward.